CEMIP and metastatic malignant neoplasm in the lymph nodes: As shown in Table 1, lymph node metastasis (31.07 ± 15.021 vs. 43.16 ± 15.539, p < 0.05) and high stage (31.00 ± 18.199 vs. 41.29 ± 13.805, p < 0.05) were associated with a significant poor OS as well as patients with KIAA1199 protein overexpression (36.48 ± 15.351 vs. 45.79 ± 15.982, p < 0.05).